RecruitingNCT07455942

Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer

Sponsor

Centre Hospitalier Intercommunal Creteil

Enrollment

300 participants

Start Date

Jun 23, 2026

Study Type

OBSERVATIONAL

Conditions

Squamous Cell Carcinoma of the Anal Canal HPV-induced Cancer

Summary

This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying self-administered questionnaire for people with hpv-induced cancer and squamous cell carcinoma of the anal canal. The study is currently recruiting participants at 32 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERself-administered questionnaire

Completion of a self-administered questionnaire by the patient to collect information about their care journey, any difficulties or hesitations, as well as their knowledge of the link between papillomavirus and cancer.

Locations(32)

CHU Angers

Angers, France

CH Avignon

Avignon, France

Clinique Belharra

Bayonne, France

CH Béthune

Beuvry, France

CH du Haut Anjou

Château-Gontier, France

Polyclinique du Parc Vivalto

Cholet, France

Centre Hospitalier Intercommunal de Créteil

Créteil, France

CH Annecy Genevois

Épagny, France

Clinique du Palais

Grasse, France

CH Vendée

La Roche-sur-Yon, France

Cabinet de proctologie

Le Bouscat, France

CH Lens

Lens, France

Hôpital St Joseph St Luc

Lyon, France

CHU Hôpital Nord - Marseille

Marseille, France

CHU Montpellier

Montpellier, France

Institut régional du Cancer de Montpellier (ICM)

Montpellier, France

CHU Orléans

Orléans, France

Hôpital Paris Saclay, GHNE

Orsay, France

APHP_Hôpital Cochin-Port Royal

Paris, France

Hôpital Saint Joseph

Paris, France

Institut Mutualiste de Montsouris

Paris, France

APHP_Hôpital Bichat Claude-Bernard

Paris, France

APHP Hôpital Tenon

Paris, France

Groupe Hospitalier Diaconesses Croix Saint-Simon

Paris, France

Polyclinique Pau Pyrénées

Pau, France

CHI Poissy-St Germain

Poissy, France

Maison des consultations

Quint-Fonsegrives, France

CHRU Ponchaillou de Rennes

Rennes, France

Clinique Saint-Grégoire

Saint-Grégoire, France

Hia Begin

Saint-Mandé, France

Hôpital Bagatelle

Talence, France

Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges

Villeneuve-Saint-Georges, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07455942

Related Trials

Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)

NCT0566118815 locations